U.S., Jan. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07316621) titled 'Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives' on Dec. 05, 2025.
Brief Summary: The PREDICT-CD study aims to validate a risk score for the development of Crohn's disease, based on serological biomarkers and lifestyle-related factors. Given that having a family member with the disease is the strongest known risk factor, the target population will consist of first-degree relatives (aged 16 to 35) of individuals diagnosed with Crohn's disease.
This study will be conducted within Work Package 3 (WP3) of the INTERCEPT project, a consortium funded by the Innovative Health Initiative (IHI). The rese...